Spots Global Cancer Trial Database for yttrium y 90 glass microspheres
Every month we try and update this database with for yttrium y 90 glass microspheres cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery | NCT00532740 | Liver Cancer Metastatic Canc... | Yttrium Y 90 gl... | 18 Years - | Northwestern University | |
| Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery | NCT00039078 | Liver Cancer | yttrium Y 90 gl... | 18 Years - 120 Years | University of Pittsburgh | |
| Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery | NCT02072356 | Adult Primary H... Advanced Adult ... Localized Unres... Recurrent Adult... | yttrium Y 90 gl... laboratory biom... TheraSphere | 8 Years - | Ohio State University Comprehensive Cancer Center | |
| Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | NCT00530010 | Liver Cancer | yttrium Y 90 gl... | 18 Years - | Northwestern University | |
| Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular Carcinoma | NCT01176604 | Stage III Hepat... Stage IIIA Hepa... Stage IIIB Hepa... Stage IV Hepato... Stage IVA Hepat... Stage IVB Hepat... Unresectable He... | Yttrium Y 90 Gl... | - | M.D. Anderson Cancer Center | |
| Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery | NCT00436267 | Metastatic Canc... Pancreatic Canc... | fluorouracil selective exter... tomotherapy yttrium Y 90 gl... yttrium Y 90 re... | 18 Years - | National Cancer Institute (NCI) | |
| Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | NCT00589030 | Liver Cancer | brachytherapy yttrium Y 90 gl... | 18 Years - | City of Hope Medical Center | |
| Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery | NCT00109954 | Liver Cancer | cisplatin brachytherapy yttrium Y 90 gl... | 18 Years - 120 Years | University of Pittsburgh | |
| Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer | NCT02837029 | Stage IIIA Hepa... Stage IIIB Hepa... Stage IIIC Hepa... Stage IVA Hepat... Stage IVB Hepat... | Laboratory Biom... Nivolumab Yttrium Y 90 Gl... | 18 Years - | Northwestern University | |
| Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | NCT00589030 | Liver Cancer | brachytherapy yttrium Y 90 gl... | 18 Years - | City of Hope Medical Center | |
| Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection | NCT03812562 | Hepatocellular ... | Nivolumab Yttrium Y 90 Gl... | 18 Years - | Northwestern University | |
| Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery | NCT00436267 | Metastatic Canc... Pancreatic Canc... | fluorouracil selective exter... tomotherapy yttrium Y 90 gl... yttrium Y 90 re... | 18 Years - | National Cancer Institute (NCI) | |
| Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases | NCT00858429 | Liver Cancer Metastatic Canc... | capecitabine yttrium Y 90 gl... | 18 Years - 120 Years | Northwestern University | |
| Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial | NCT06432036 | Stage I Renal C... Stage II Renal ... | Angiogram Biospecimen Col... Computed Tomogr... Radioembolizati... Single Photon E... Survey Administ... Yttrium Y 90 Gl... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D) | NCT03896646 | Stage III Hepat... Stage IIIA Hepa... Stage IIIB Hepa... Stage IV Hepato... Stage IVA Hepat... Stage IVB Hepat... Unresectable He... | Computed Tomogr... Hepatobiliary I... Single Photon E... Yttrium Y 90 Gl... Yttrium-90 Micr... | 18 Years - | M.D. Anderson Cancer Center | |
| Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer | NCT02837029 | Stage IIIA Hepa... Stage IIIB Hepa... Stage IIIC Hepa... Stage IVA Hepat... Stage IVB Hepat... | Laboratory Biom... Nivolumab Yttrium Y 90 Gl... | 18 Years - | Northwestern University | |
| Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery | NCT00956930 | Liver Cancer | yttrium Y 90 gl... Doxorubicin | 18 Years - 120 Years | Northwestern University | |
| Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases | NCT00858429 | Liver Cancer Metastatic Canc... | capecitabine yttrium Y 90 gl... | 18 Years - 120 Years | Northwestern University | |
| Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular Carcinoma | NCT01176604 | Stage III Hepat... Stage IIIA Hepa... Stage IIIB Hepa... Stage IV Hepato... Stage IVA Hepat... Stage IVB Hepat... Unresectable He... | Yttrium Y 90 Gl... | - | M.D. Anderson Cancer Center | |
| Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery | NCT00436267 | Metastatic Canc... Pancreatic Canc... | fluorouracil selective exter... tomotherapy yttrium Y 90 gl... yttrium Y 90 re... | 18 Years - | National Cancer Institute (NCI) | |
| Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular Carcinoma | NCT01176604 | Stage III Hepat... Stage IIIA Hepa... Stage IIIB Hepa... Stage IV Hepato... Stage IVA Hepat... Stage IVB Hepat... Unresectable He... | Yttrium Y 90 Gl... | - | M.D. Anderson Cancer Center | |
| Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial | NCT06432036 | Stage I Renal C... Stage II Renal ... | Angiogram Biospecimen Col... Computed Tomogr... Radioembolizati... Single Photon E... Survey Administ... Yttrium Y 90 Gl... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery | NCT00532740 | Liver Cancer Metastatic Canc... | Yttrium Y 90 gl... | 18 Years - | Northwestern University | |
| Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | NCT00589030 | Liver Cancer | brachytherapy yttrium Y 90 gl... | 18 Years - | City of Hope Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
